Pine Valley Investments LTD Liability CO Glycomimetics Inc Transaction History
Pine Valley Investments LTD Liability CO
- $1.67 Trillion
- Q4 2024
A detailed history of Pine Valley Investments LTD Liability CO transactions in Glycomimetics Inc stock. As of the latest transaction made, Pine Valley Investments LTD Liability CO holds 12,520 shares of GLYC stock, worth $3,630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,520
Previous 12,520
-0.0%
Holding current value
$3,630
Previous $2.12 Million
47.35%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GLYC
# of Institutions
37Shares Held
27.3MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA9.54MShares$2.77 Million0.09% of portfolio
-
Logos Global Management LP San Francisco, CA5.4MShares$1.57 Million0.18% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.09MShares$1.48 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3MShares$869,9990.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$774,3600.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $15.2M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...